152 related articles for article (PubMed ID: 36999620)
1. Real-time continuous glucose monitoring immediately after severe hypoglycaemia requiring emergency medical services: A randomised controlled trial.
Uduku C; Pendolino V; Jugnee N; Oliver N; Fothergill R; Reddy M
Diabet Med; 2023 Jul; 40(7):e15100. PubMed ID: 36999620
[TBL] [Abstract][Full Text] [Related]
2. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial.
Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
Lancet Diabetes Endocrinol; 2023 Feb; 11(2):96-108. PubMed ID: 36702566
[TBL] [Abstract][Full Text] [Related]
3. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
[TBL] [Abstract][Full Text] [Related]
4. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
[TBL] [Abstract][Full Text] [Related]
5. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.
Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
Lancet; 2021 Jun; 397(10291):2275-2283. PubMed ID: 34089660
[TBL] [Abstract][Full Text] [Related]
6. Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
Avari P; Uduku C; George D; Herrero P; Reddy M; Oliver N
Diabetes Technol Ther; 2020 Mar; 22(3):222-227. PubMed ID: 31613142
[No Abstract] [Full Text] [Related]
7. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial.
Hásková A; Radovnická L; Petruželková L; Parkin CG; Grunberger G; Horová E; Navrátilová V; Kádě O; Matoulek M; Prázný M; Šoupal J
Diabetes Care; 2020 Nov; 43(11):2744-2750. PubMed ID: 32859607
[TBL] [Abstract][Full Text] [Related]
8. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
[TBL] [Abstract][Full Text] [Related]
9. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
Jancev M; Vissers TACM; Visseren FLJ; van Bon AC; Serné EH; DeVries JH; de Valk HW; van Sloten TT
Diabetologia; 2024 May; 67(5):798-810. PubMed ID: 38363342
[TBL] [Abstract][Full Text] [Related]
10. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia.
Reddy M; Jugnee N; El Laboudi A; Spanudakis E; Anantharaja S; Oliver N
Diabet Med; 2018 Apr; 35(4):483-490. PubMed ID: 29230878
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
Puhr S; Calhoun P; Welsh JB; Walker TC
Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
[TBL] [Abstract][Full Text] [Related]
14. High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study.
Farrell CM; McNeilly AD; Hapca S; Fournier PA; Jones TW; Facchinetti A; Cappon G; West DJ; McCrimmon RJ
Diabetologia; 2024 Feb; 67(2):392-402. PubMed ID: 38010533
[TBL] [Abstract][Full Text] [Related]
15. Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study.
Radovnická L; Hásková A; Do QD; Horová E; Navrátilová V; Mikeš O; Cihlář D; Parkin CG; Grunberger G; Prázný M; Šoupal J
Diabetes Technol Ther; 2022 Dec; 24(12):859-867. PubMed ID: 36037056
[No Abstract] [Full Text] [Related]
16. Rationale and protocol for the Assessment of Impact of Real-time Continuous Glucose Monitoring on people presenting with severe Hypoglycaemia (AIR-CGM) study.
Avari P; Ramli R; Reddy M; Oliver N; Fothergill R
BMC Endocr Disord; 2019 Oct; 19(1):110. PubMed ID: 31655586
[TBL] [Abstract][Full Text] [Related]
17. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
Reddy M; Jugnee N; Anantharaja S; Oliver N
Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
[TBL] [Abstract][Full Text] [Related]
18. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
[TBL] [Abstract][Full Text] [Related]
19. Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium.
Visser MM; Van Muylder A; Charleer S; Isitt JJ; Roze S; De Block C; Maes T; Vanhaverbeke G; Nobels F; Keymeulen B; Mathieu C; Luyten J; Gillard P; Verhaeghe N
Diabetologia; 2024 Apr; 67(4):650-662. PubMed ID: 38236409
[TBL] [Abstract][Full Text] [Related]
20. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia.
Oliver N; Gimenez M; Calhoun P; Cohen N; Moscardo V; Hermanns N; Freckmann G; Reddy M; Heinemann L
Diabetes Care; 2020 Jan; 43(1):53-58. PubMed ID: 31530662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
